News/Media
Our Latest Updates & News
Lectenz Bio at 2018 Society for Glycobiology Annual Meeting
Society for Glycobiology Annual Meeting 2018 Visit us at Lectenz Bio Booth #9! Hilton New Orleans Riverside - New Orleans, LAMonday, Nov....
CEO and CSO Lori Yang presents at the 2nd GlycoCom in Dubrovnik, Croatia
CEO and CSO Lori Yang gave a talk titled "Novel tools for glycan detection and analysis" at the 2nd GlycoCom and 1st Human Glycome Project...
Lectenz Bio receives NIH SBIR Fast-Track
The National Institute of Health (NIH) Office of Research Infrastructure Programs (ORIP) awards Lectenz Bio an SBIR Fast-Track to develop...
Research Scientist Matthew Saunders presents at CYTO 2018
Research Scientist Matthew Saunders presented a poster and gave a CYTO Innovation talk on GlycoSenseTM: A Rapid Method for Monitoring...
Interim CEO and CSO Lori Yang presents at the 2018 ASBMB Annual Meeting
Interim CEO and CSO Lori Yang presented two posters and gave a talk on GlycoSenseTM: A Rapid Method for Monitoring In Vitro...
Director of Operations Sean Wu presents at the 12th Georgia Glycoscience Symposium
Director of Operations Sean Wu presented a poster and gave a talk on sialoglycoconjugate detection and enrichment products. Learn more...
Lectenz Bio receives patent issuance from USPTO
The Lectenz Bio team is excited to announce the approval of its patent for the Lectenz® platform technology. This paves the way...
Lectenz Bio receives NIH SBIR Phase II
The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further develop sialic...
Lectenz Bio receives NIH SBIR Phase I
The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio a second SBIR Phase I to apply the...
Browse our products
